FDA Approves Capvaxive Pneumococcal 21-Valent Conjugate Vaccine

FDA approves Nasal Spray Influenza Vaccine for self- or caregiver-administration

caribbeannewsglobal.com - 22/Sep 13:12

First Influenza Vaccine that does not need to be administered by a Health Care Provider ATLANTA, USA – The US Food and Drug Administration approved...

FDA Approves First Flu Vaccine That Can Be Self-Administered at Home

drugs.com - 20/Sep 22:09

FRIDAY, Sept. 20, 2024 -- On Friday, the U.S. Food and Drug Administration approved the FluMist nasal vaccine for self-administration at home. It is a...

FDA Approves Miplyffa for Treatment of Niemann-Pick Disease, Type C

drugs.com - 22:09

MONDAY, Sept. 30, 2024 -- The U.S. Food and Drug Administration has approved Miplyffa (arimoclomol), an oral medication for the treatment of...

FDA Approves First Flu Vaccine You Give Yourself at Home

drugs.com - 20/Sep 17:20

FRIDAY, Sept. 20, 2024 -- The days of waiting for a flu shot at your doctor's office or local pharmacy may be over: The U.S. Food and Drug...

FDA Approves First Flu Vaccine You Give Yourself at Home, FluMist

drugs.com - 20/Sep 17:09

FRIDAY, Sept. 20, 2024 -- The days of waiting for a flu shot at your doctor's office or local pharmacy may be over: The U.S. Food and Drug...

FDA Approves Aqneursa (levacetylleucine) for the Treatment of Niemann-Pick Disease Type C

drugs.com - 25/Sep 07:09

AUSTIN, TX, September 25, 2024– IntraBio Inc., a leader in the discovery and development of innovative drugs for rare neurodegenerative...

FDA Approves Tremfya for Ulcerative Colitis

drugs.com - 16/Sep 22:24

MONDAY, Sept. 16, 2024 -- The U.S. Food and Drug Administration has approved Tremfya (guselkumab) for the treatment of adults with moderately to...

FDA Approves Tremfya for Ulcerative Colitis

drugs.com - 16/Sep 22:24

MONDAY, Sept. 16, 2024 -- The U.S. Food and Drug Administration has approved Tremfya (guselkumab) for the treatment of adults with moderately to...

FDA Approves Ebglyss for Moderate-to-Severe Atopic Dermatitis

drugs.com - 18/Sep 22:23

WEDNESDAY, Sept. 18, 2024 -- The U.S. Food and Drug Administration has approved Ebglyss (lebrikizumab-lbkz) for adults and children aged 12 years and...

FDA Approves Miplyffa (arimoclomol) for the Treatment of Niemann-Pick Disease Type C

drugs.com - 20/Sep 05:09

CELEBRATION, Fla., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage rare...

Rubriques :

FDA Approves Capvaxive Pneumococcal 21-Valent Conjugate Vaccine

Articles similaires

FDA approves Nasal Spray Influenza Vaccine for self- or caregiver-administration

FDA Approves First Flu Vaccine That Can Be Self-Administered at Home

FDA Approves Miplyffa for Treatment of Niemann-Pick Disease, Type C

FDA Approves First Flu Vaccine You Give Yourself at Home

FDA Approves First Flu Vaccine You Give Yourself at Home, FluMist

FDA Approves Aqneursa (levacetylleucine) for the Treatment of Niemann-Pick Disease Type C

FDA Approves Tremfya for Ulcerative Colitis

FDA Approves Tremfya for Ulcerative Colitis

FDA Approves Ebglyss for Moderate-to-Severe Atopic Dermatitis

FDA Approves Miplyffa (arimoclomol) for the Treatment of Niemann-Pick Disease Type C

Les derniers communiqués